Funding Rounds
Translate Bio Venture round, May 3, 2019
Translate BioTranslate Bio is a clinical-stage mRNA therapeutics company developing medicines to treat diseases caused by protein or gene dysfunction and vaccines against infectious disease pathogens.
Summary
Stage: Unknown
Raised Amount: $47.50M
Raised Date: 2019-05-03